Manufacturers Life Insurance Company, The Halozyme Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$103 Billion
Q1 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 267,673 shares of HALO stock, worth $14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

267,673

Previous 249,878 7.12%

Holding current value

$14 Million

Previous $9.24 Million 17.9%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $599,335 - $746,500	17,795 Added 7.12%	267,673 $10.9 Million
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $137,378 - $173,578	-4,123 Reduced 1.62%	249,878 $9.24 Million
Q3 2023 Nov 15, 2023	BUY	$36.46 - $44.03 $1.24 Million - $1.49 Million	33,890 Added 15.4%	254,001 $9.7 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $30,461 - $38,972	-1,006 Reduced 0.45%	220,111 $7.94 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $75,216 - $127,497	-2,289 Reduced 1.04%	218,828 $8.36 Million

Q4 2022 Aug 11, 2023	SELL	$40.06 - $59.44 $636,673 - $944,679	-15,893 Reduced 6.71%	221,117 $12.6 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $636,673 - $944,679	-15,893 Reduced 6.71%	221,117 $12.6 Million
Q3 2022 Aug 11, 2023	SELL	$38.53 - $51.78 $383,103 - $514,848	-9,943 Reduced 4.03%	237,010 $9.37 Million
Q3 2022 Nov 03, 2022	SELL	$38.53 - $51.78 $383,103 - $514,848	-9,943 Reduced 4.03%	237,010 $9.37 Million
Q2 2022 Aug 11, 2023	SELL	$37.35 - $48.3 $32,046 - $41,441	-858 Reduced 0.35%	246,953 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $32,046 - $41,441	-858 Reduced 0.35%	246,953 $11 Million
Q1 2022 Aug 11, 2023	BUY	$31.97 - $41.06 $926,586 - $1.19 Million	28,983 Added 13.24%	247,811 $9.88 Million
Q1 2022 May 20, 2022	BUY	$31.97 - $41.06 $683,294 - $877,575	21,373 Added 9.44%	247,811 $9.91 Million
Q4 2021 Feb 16, 2022	SELL	$31.82 - $40.75 $6.53 Million - $8.36 Million	-205,111 Reduced 47.53%	226,438 $9.11 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $8.01 Million - $9.67 Million	208,314 Added 93.32%	431,549 $17.6 Million
Q2 2021 Aug 12, 2021	BUY	$38.84 - $51.31 $319,187 - $421,665	8,218 Added 3.82%	223,235 $10.1 Million
Q1 2021 May 03, 2021	SELL	$39.51 - $51.45 $587,000 - $764,392	-14,857 Reduced 6.46%	215,017 $8.96 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $3.9 Million - $6.6 Million	151,245 Added 192.35%	229,874 $9.82 Million
Q3 2020 Nov 09, 2020	SELL	$25.74 - $29.63 $57,631 - $66,341	-2,239 Reduced 2.77%	78,629 $2.07 Million
Q2 2020 Aug 10, 2020	SELL	$16.25 - $26.81 $108,777 - $179,466	-6,694 Reduced 7.64%	80,868 $2.09 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $21,239 - $33,356	1,528 Added 1.78%	87,562 $1.58 Million
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $44,327 - $57,984	-2,969 Reduced 3.34%	86,034 $1.53 Million
Q3 2019 Nov 12, 2019	SELL	$15.2 - $17.69 $4,438 - $5,165	-292 Reduced 0.33%	89,003 $1.35 Million
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $103,073 - $120,612	6,988 Added 8.49%	89,295 $1.53 Million
Q1 2019 May 13, 2019	BUY	$13.94 - $17.58 $69,839 - $88,075	5,010 Added 6.48%	82,307 $1.33 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $57,385 - $80,331	-4,305 Reduced 5.28%	77,297 $1.13 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $11.7 Million - $12.9 Million	-703,299 Reduced 89.6%	81,602 $1.48 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $350,254 - $421,468	20,762 Added 2.72%	784,901 $13.2 Million
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $813,028 - $1.01 Million	47,657 Added 6.65%	764,139 $15 Million
Q4 2017 Feb 08, 2018	SELL	$16.75 - $20.8 $2.35 Million - $2.91 Million	-140,093 Reduced 16.36%	716,482 $14.5 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $10.1 Million - $14.9 Million	856,575	856,575 $14.9 Million

Others Institutions Holding HALO

# of Institutions

441

Shares Held

122M

Call Options Held

216K

Put Options Held

140K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.29B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Halozyme Therapeutics, Inc. Transaction History